Oblimersen and Doxorubicin in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)
NCT00047229
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
27
Enrollment
OTHER
Sponsor class
Conditions
Liver Cancer
Interventions
BIOLOGICAL:
oblimersen sodium
DRUG:
doxorubicin hydrochloride
Sponsor
University Health Network, Toronto
Collaborators
[object Object]